Exclusive: SEC investigates allegations of misspending by Dow Chemical CEO – sources

NEW YORK (Reuters) – The U.S. Securities and Exchange Commission is investigating allegations that Andrew Liveris, chairman and chief executive officer of industrial giant Dow Chemical Co , misused company funds for personal benefit, according to people familiar with the matter.





Source: Business

Leave a Reply

Your email address will not be published. Required fields are marked *

one × one =